STEMLINE THERAPEUTICS, INC.
Share on:
| Name: | STEMLINE THERAPEUTICS, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 15 Sep 2003 (22 years ago) |
| Entity Number: | 2954095 |
| ZIP code: | 10022 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 750 Lexington Avenue, 4TH FLOOR, New York, NY, United States, 10022 |
| Principal Address: | 750 LEXINGTON AVE, 4TH FLOOR, NEW YORK, NY, United States, 10022 |
| Name | Role | Address |
|---|---|---|
| IVAN BERGSTEIN, MD | Chief Executive Officer | 750 LEXINGTON AVE, 4TH FLOOR, NEW YORK, NY, United States, 10022 |
| Name | Role | Address |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | DOS Process Agent | 750 Lexington Avenue, 4TH FLOOR, New York, NY, United States, 10022 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2023-09-19 | 2023-09-19 | Address | 750 LEXINGTON AVE, 11TH FLOOR, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
| 2023-09-19 | 2023-09-19 | Address | 750 LEXINGTON AVE, 4TH FLOOR, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
| 2019-09-03 | 2023-09-19 | Address | 750 LEXINGTON AVE, 11TH FLOOR, NEW YORK, NY, 10022, USA (Type of address: Service of Process) |
| 2015-01-02 | 2023-09-19 | Address | 750 LEXINGTON AVE, 11TH FLOOR, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
| 2015-01-02 | 2019-09-03 | Address | IVAN BERGSTEIN, MD, 750 LEXINGTON AVE / 11TH FL, NEW YORK, NY, 10022, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 230919002391 | 2023-09-19 | BIENNIAL STATEMENT | 2023-09-01 |
| 210909001475 | 2021-09-09 | BIENNIAL STATEMENT | 2021-09-09 |
| 190903063014 | 2019-09-03 | BIENNIAL STATEMENT | 2019-09-01 |
| 180122006092 | 2018-01-22 | BIENNIAL STATEMENT | 2017-09-01 |
| 150903006617 | 2015-09-03 | BIENNIAL STATEMENT | 2015-09-01 |
This company hasn't received any reviews.
Date of last update: 29 Mar 2025
Sources: New York Secretary of State